These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11692656)

  • 1. An appraisal of chemotherapy: in the blood or in the brain?
    Schmidt MH; Chang SM; Berger MS
    Clin Neurosurg; 2001; 48():46-59. PubMed ID: 11692656
    [No Abstract]   [Full Text] [Related]  

  • 2. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.
    Haluska M; Anthony ML
    Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain metastases from lung cancer: chemotherapy.
    Schuette W
    Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thrill of victory; the agony of defeat.
    Turrisi AT
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1300-2. PubMed ID: 18374219
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of high-grade astrocytomas.
    Lesser GJ; Grossman S
    Semin Oncol; 1994 Apr; 21(2):220-35. PubMed ID: 8153666
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose combination chemotherapy: why, how, and when.
    Israël L
    Mt Sinai J Med; 1985 Jun; 52(6):447-51. PubMed ID: 3875024
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the blood-brain barrier relevant in metastatic germ cell tumor?
    Azar JM; Schneider BP; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):163-6. PubMed ID: 17707269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic analysis and individualized therapy for diffuse glioma].
    Watanabe T; Yoshino A; Katayama Y
    No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of brain metastases.
    Korfel A; Thiel E
    Front Radiat Ther Oncol; 1999; 33():343-8. PubMed ID: 10549505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 18. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM
    Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug cocktails for effective treatment of glioblastoma multiforme.
    Debinski W
    Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.